17 results
·
27ms
·
Sources: EU EUDAMED, US FDA
ALEXANDER MANUFACTURING CO. RECHARGEABLE BATTERY PART NUMBER GL4018
FDA 510(k)
FDA Class 2
·General Hospital
PEEK Corpectomy
FDA UDI
Nuvasive, Inc.·00887517623027·PEEK Corp Core, Ø12x12mm
Key Surgical K-Wires and Steinmann Pins
FDA UDI
KEY SURGICAL, INC.·00849771012795·K-Wires, Double diamond, .045-inch (1.1mm) diam...
KMEDIC
FDA UDI
TELEFLEX INCORPORATED·24026704293043·
NA
FDA UDI
KEY SURGICAL, INC.·10849771049415·K-Wires, Double diamond, .045-inch (1.1mm) diam...
mahe medical GmbH
FDA UDI
mahe medical gmbh·04050659484559·K-Wire w. double end lanzet point _x000D_...
K-Wire w. double end lanzet point 1.1mm/229mm, 6 pcs./unit
FDA UDI
mahe medical gmbh·EMAHKM712120·K-Wire w. double end lanzet point
1.1mm/...
Tx™
FDA UDI
INNO Holdings, Inc.·M711LS39712120·Ti 6Al 4V (ELI)
ESPRIT VENTILATOR SPEAKING MODE OPTION, MODEL V1000
FDA 510(k)
FDA Class 2
·Anesthesiology
AirFit N20
FDA 510(k)
FDA Class 2
·Anesthesiology
PRECISION QID
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE INC·Product code NBW·January 26, 2017
PRECISION XTRA
FDA Adverse Event
Malfunction
·ABBOTT DIABETES CARE INC·Product code NBW·January 26, 2017
9900
FDA Adverse Event
Malfunction
·GE OEC MEDICAL SYSTEMS (SLC)·Product code JAA·February 1, 2013
PRECISION XTRA
FDA Adverse Event
Malfunction
·Product code NBW·January 26, 2011
PORTABLE OXYGEN GENERATOR (CONCENTRATOR, HOMEFILL)
FDA Adverse Event
Malfunction
·INVACARE FLORIDA OPERATIONS·Product code CAW·July 31, 2014
STRONG ARM
FDA Adverse Event
Injury
·SYNTHES MONUMENT·Product code HXD·October 10, 2014
Anthem Model Numbers: PM3210, PM3212; Allure/Relieve Model Numbers: PM3222, PM3242, PM3262, PM3542, PM3224, PM3244 Implantation of a single-chamber pulse generator, dual-chamber pulse generator, or CRT-P is indicated in one or more of the following permanent conditions: Syncope, Presyncope, Fatigue, Disorientation, Or any combination of those symptoms. Implantation of a CRT-P is indicated for: Maintaining synchrony of the left and right ventricles in patients who have undergone an AV nodal ablation for chronic atrial fibrillation and have NYHA Class II or III heart failure. The reduction of the symptoms of moderate to severe heart failure (NYHA Class III or IV) in those patients who remain symptomatic despite stable, optimal medical therapy, and have a left ventricular ejection fraction d35% and a prolonged QRS duration
FDA Enforcement
Class II
·Terminated·St Jude Medical Inc.·October 25, 2017